<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01944878</url>
  </required_header>
  <id_info>
    <org_study_id>BCS-1</org_study_id>
    <nct_id>NCT01944878</nct_id>
  </id_info>
  <brief_title>The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient</brief_title>
  <official_title>Retrospective Observational Study of Impact of Portal Hypertension for the Peptic Ulcer in Liver Cirrhosis and Chronic Hepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chuncheon Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chuncheon Sacred Heart Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the role of portal hypertension of peptic ulcer disease in
      liver cirrhosis and chronic hepatitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective case-control study

        -  Investigators will analyze the medical records of hepatic vein pressure gradient (HVPG)
           and esophagogastroduodenoscopy (EGD) cases who had liver cirrhosis (LC) or chronic
           hepatitis in a single tertiary hospital (Chuncheon Sacred Heart hospital, Korea) within
           2008~2012.

        -  Portal hypertension is assessed using HVPG measurement via transjugular approach.

        -  Peptic ulcer is evaluated through EGD within 3 months of HVPG measurement

        -  The association of Peptic ulcer with LC, chronic hepatitis and total population (LC or
           chronic hepatitis) will be assessed by univariate and multivariate analysis

        -  There is no specific time frame, because this study is retrospective observational
           study, however EGD data is enrolled if it was done within 3 month from HVPG measurement.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Association of HVPG and PUD in Patients With Liver Cirrhosis</measure>
    <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
    <description>The association of hepatic vein pressure gradient that reflects portal hypertension and peptic ulcer disease in patients with liver cirrhosis was assessed statistically.
(NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The Mann-Whitney test was used to evaluate the association between PUD or not and HVPG degree, by SPSS software.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Association Between PUD and HVPG in Patients With Chronic Hepatitis</measure>
    <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">455</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Chronic Liver Disease</condition>
  <arm_group>
    <arm_group_label>Patients with chronic hepatitis</arm_group_label>
    <description>Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with liver cirrhosis</arm_group_label>
    <description>Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators will analyze the medical records of hepatic vein pressure gradient (HVPG) and
        esophagogastroduodenoscopy (EGD) cases who had LC or chronic hepatitis in single tertiary
        hospital of Korea.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients who underwent hepatic vein pressure gradient (HVPG) measurement and
             esophagogastroduodenoscopy (EGD) and also had LC or chronic hepatitis

        Exclusion Criteria:

          -  The patients who have missing or incomplete HVPG or EGD data

          -  The patients who underwent gastrectomy

          -  The patients who have systemic malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Seok Bang, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine, Hallym University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gwang Ho Baik, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Internal Medicine, Hallym University College of Internal Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chuncheon Sacred Heart hospital</name>
      <address>
        <city>Chuncheon</city>
        <state>Gangwon-do</state>
        <zip>200-704</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Siringo S, Burroughs AK, Bolondi L, Muia A, Di Febo G, Miglioli M, Cavalli G, Barbara L. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol. 1995 Jun;22(6):633-41.</citation>
    <PMID>7560857</PMID>
  </reference>
  <reference>
    <citation>Vergara M, Calvet X, Roqu√© M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol. 2002 Jul;14(7):717-22.</citation>
    <PMID>12169979</PMID>
  </reference>
  <reference>
    <citation>Kamalaporn P, Sobhonslidsuk A, Jatchavala J, Atisook K, Rattanasiri S, Pramoolsinsap C. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1459-65.</citation>
    <PMID>15948813</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2013</study_first_submitted>
  <study_first_submitted_qc>September 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2013</study_first_posted>
  <results_first_submitted>January 23, 2014</results_first_submitted>
  <results_first_submitted_qc>July 22, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 24, 2014</results_first_posted>
  <last_update_submitted>July 22, 2014</last_update_submitted>
  <last_update_submitted_qc>July 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chuncheon Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Chang Seok Bang</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Peptic ulcer</keyword>
  <keyword>Liver cirrhosis</keyword>
  <keyword>Portal hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We analyzed the medical records of 455 hepatic vein pressure gradient (HVPG) and esophagogastroduodenoscopy (EGD) patients who had LC or chronic hepatitis in a single tertiary hospital.</recruitment_details>
      <pre_assignment_details>800 HVPG measurement cases (Initial). Missing data (3), failure of HVPG measurements (8), cases without EGD (196); including 35 cases of patients on B-blocker, EGD over 3 months from HVPG measurement (79), incomplete EGD due to remnant food materials (19), cases having a history of gastrectomy (5), acute hepatopathy (5), and HCC (30) were excluded.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Patients With Chronic Hepatitis</title>
          <description>Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
        </group>
        <group group_id="P2">
          <title>Patients With Liver Cirrhosis</title>
          <description>Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="328"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="328"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>A total of 127 patients with chronic hepatitis and 328 patients with liver cirrhosis were enrolled.</population>
      <group_list>
        <group group_id="B1">
          <title>Patients With Chronic Hepatitis</title>
          <description>Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
        </group>
        <group group_id="B2">
          <title>Patients With Liver Cirrhosis</title>
          <description>Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="127"/>
            <count group_id="B2" value="328"/>
            <count group_id="B3" value="455"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>This is the median age and interquartile range of enrolled patients divided by group (chronic hepatitis vs. liver cirrhosis)</description>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45" lower_limit="37" upper_limit="54"/>
                    <measurement group_id="B2" value="52" lower_limit="46" upper_limit="59"/>
                    <measurement group_id="B3" value="50" lower_limit="44" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>The number of gender distribution is described in each group here.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="258"/>
                    <measurement group_id="B3" value="339"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HVPG (mmHg)</title>
          <description>HVPG (Hepatic vein pressure gradient) was measured in the enrolled population. HVPG reflects portal pressure of patient. To find the relationship between peptic ulcer disease and portal hypertension, the Fisher's exact test was performed.</description>
          <units>mmHg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.5" lower_limit="2" upper_limit="5.5"/>
                    <measurement group_id="B2" value="15" lower_limit="10.78" upper_limit="20"/>
                    <measurement group_id="B3" value="12" lower_limit="5" upper_limit="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PUD</title>
          <description>This is the number of peptic ulcer disease patients in the each group (patients with chronic hepatitis vs. patients with liver cirrhosis)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medication (NSAIDs, aspirin, clopidogrel, ticlopidine, steroid)</title>
          <description>The number of patients who taking medication in each group is described here.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>smoking</title>
          <description>The number of smokers in each group is described here.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="164"/>
                    <measurement group_id="B3" value="203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>alcoholc</title>
          <description>The number of alcoholics in each group is described here.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="233"/>
                    <measurement group_id="B3" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Association of HVPG and PUD in Patients With Liver Cirrhosis</title>
        <description>The association of hepatic vein pressure gradient that reflects portal hypertension and peptic ulcer disease in patients with liver cirrhosis was assessed statistically.
(NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The Mann-Whitney test was used to evaluate the association between PUD or not and HVPG degree, by SPSS software.</description>
        <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PUD in Liver Cirrhosis</title>
            <description>Patients with PUD in liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
          </group>
          <group group_id="O2">
            <title>No PUD in Liver Cirrhosis</title>
            <description>Patients without PUD in liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
          </group>
        </group_list>
        <measure>
          <title>The Association of HVPG and PUD in Patients With Liver Cirrhosis</title>
          <description>The association of hepatic vein pressure gradient that reflects portal hypertension and peptic ulcer disease in patients with liver cirrhosis was assessed statistically.
(NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The Mann-Whitney test was used to evaluate the association between PUD or not and HVPG degree, by SPSS software.</description>
          <units>mmHg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.5" lower_limit="11.5" upper_limit="19.5"/>
                    <measurement group_id="O2" value="15.3" lower_limit="10.2" upper_limit="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Association Between PUD and HVPG in Patients With Chronic Hepatitis</title>
        <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PUD in Chronic Hepatitis</title>
          </group>
          <group group_id="O2">
            <title>No PUD in Lchronic Hepatitis</title>
          </group>
        </group_list>
        <measure>
          <title>The Association Between PUD and HVPG in Patients With Chronic Hepatitis</title>
          <units>mmHg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="2.15" upper_limit="5.3"/>
                    <measurement group_id="O2" value="3.4" lower_limit="2" upper_limit="5.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Patients With Chronic Hepatitis</title>
          <description>Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
        </group>
        <group group_id="E2">
          <title>Patients With Liver Cirrhosis</title>
          <description>Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="328"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="328"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Chang Seok Bang</name_or_title>
      <organization>Hallym University College of Medicine, Chuncheon Sacred Heart Hospital</organization>
      <phone>+82-33-240-5000</phone>
      <email>cloudslove@naver.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

